Premixed Insulin Analogues Help Your Patients Reach BG Goals

In three comparative randomized trials, researchers at the department of medicine at Baylor College of Medicine in Houston, Texas, demonstrated that type 2s who used premixed insulins were more likely to reach blood glucose goals than those using only Lantus once daily.

“Some patients can also reach [blood glucose] goals with once-daily administration of a premixed insulin analogue,” write the researchers, who add that within trials, the incidence of both major and minor hypoglycemia with the premixed insulin analogues Humalog Mic 75/25 and NovoLog Mix 70/30 is low.

“Premixed insulin analogues can be safely used and are effective and convenient for achieving overall [blood glucose] control in patients with diabetes,” say the researchers. “In addition, given the convenience of mealtime dose administration, compliance with insulin therapy may increase with premixed insulin analogues.”

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.